These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 31181481)

  • 1. Tetrahydropyrazolo[1,5-a]pyridine-fused steroids and their in vitro biological evaluation in prostate cancer.
    Jorda R; Lopes SMM; Řezníčková E; Ajani H; Pereira AV; Gomes CSB; M V D Pinho E Melo T
    Eur J Med Chem; 2019 Sep; 178():168-176. PubMed ID: 31181481
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis and anti-cancer activity of chiral tetrahydropyrazolo[1,5-a]pyridine-fused steroids.
    Lopes SMM; Sousa EP; Barreira L; Marques C; Rodrigues MJ; Pinho E Melo TMVD
    Steroids; 2017 Jun; 122():16-23. PubMed ID: 28342744
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A-ring-fused pyrazoles of dihydrotestosterone targeting prostate cancer cells via the downregulation of the androgen receptor.
    Peřina M; Kiss MA; Mótyán G; Szczyrbová E; Eliáš M; Študent V; Kurfürstová D; Kovalová M; Mada L; Bouchal J; Frank É; Jorda R
    Eur J Med Chem; 2023 Mar; 249():115086. PubMed ID: 36682291
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis of novel galeterone derivatives and evaluation of their in vitro activity against prostate cancer cell lines.
    Jorda R; Řezníčková E; Kiełczewska U; Maj J; Morzycki JW; Siergiejczyk L; Bazgier V; Berka K; Rárová L; Wojtkielewicz A
    Eur J Med Chem; 2019 Oct; 179():483-492. PubMed ID: 31271960
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis and biological evaluation of new steroidal pyridines as potential anti-prostate cancer agents.
    Shi YK; Wang B; Shi XL; Zhao YD; Yu B; Liu HM
    Eur J Med Chem; 2018 Feb; 145():11-22. PubMed ID: 29310026
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Zyflamend inhibits the expression and function of androgen receptor and acts synergistically with bicalutimide to inhibit prostate cancer cell growth.
    Yan J; Xie B; Capodice JL; Katz AE
    Prostate; 2012 Feb; 72(3):244-52. PubMed ID: 21656835
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Discovery of novel 5-methyl-1H-pyrazole derivatives as potential antiprostate cancer agents: Design, synthesis, molecular modeling, and biological evaluation.
    Zhang D; Asnake S; Zhang J; Olsson PE; Zhao G
    Chem Biol Drug Des; 2018 Jun; 91(6):1113-1124. PubMed ID: 29388326
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Discovery of novel androgen receptor antagonists: a hybrid approach of pharmacophore-based and docking-based virtual screening.
    Liu J; Liu B; Guo G; Jing Y; Zhao G
    Anticancer Drugs; 2015 Aug; 26(7):747-53. PubMed ID: 25933245
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Design, synthesis and antitumor activity of steroidal pyridine derivatives based on molecular docking.
    Song YL; Tian CP; Wu Y; Jiang LH; Shen LQ
    Steroids; 2019 Mar; 143():53-61. PubMed ID: 30590064
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 20-Aminosteroids as a novel class of selective and complete androgen receptor antagonists and inhibitors of prostate cancer cell growth.
    Fousteris MA; Schubert U; Roell D; Roediger J; Bailis N; Nikolaropoulos SS; Baniahmad A; Giannis A
    Bioorg Med Chem; 2010 Oct; 18(19):6960-9. PubMed ID: 20826091
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Discovery of ODM-201, a new-generation androgen receptor inhibitor targeting resistance mechanisms to androgen signaling-directed prostate cancer therapies.
    Moilanen AM; Riikonen R; Oksala R; Ravanti L; Aho E; Wohlfahrt G; Nykänen PS; Törmäkangas OP; Palvimo JJ; Kallio PJ
    Sci Rep; 2015 Jul; 5():12007. PubMed ID: 26137992
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel C-17-heteroaryl steroidal CYP17 inhibitors/antiandrogens: synthesis, in vitro biological activity, pharmacokinetics, and antitumor activity in the LAPC4 human prostate cancer xenograft model.
    Handratta VD; Vasaitis TS; Njar VC; Gediya LK; Kataria R; Chopra P; Newman D; Farquhar R; Guo Z; Qiu Y; Brodie AM
    J Med Chem; 2005 Apr; 48(8):2972-84. PubMed ID: 15828836
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Androgen receptor antagonists and anti-prostate cancer activities of some synthesized steroidal candidates.
    Bahashwan SA; Al-Omar MA; Ezzeldin E; Abdalla MM; Fayed AA; Amr AG
    Chem Pharm Bull (Tokyo); 2011; 59(11):1363-8. PubMed ID: 22041072
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Y08197 is a novel and selective CBP/EP300 bromodomain inhibitor for the treatment of prostate cancer.
    Zou LJ; Xiang QP; Xue XQ; Zhang C; Li CC; Wang C; Li Q; Wang R; Wu S; Zhou YL; Zhang Y; Xu Y
    Acta Pharmacol Sin; 2019 Nov; 40(11):1436-1447. PubMed ID: 31097763
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis and Biological Evaluation of New Isoxazolyl Steroids as Anti-Prostate Cancer Agents.
    Rudovich AS; Peřina M; Krech AV; Novozhilova MY; Tumilovich AM; Shkel TV; Grabovec IP; Kvasnica M; Mada L; Zavialova MG; Mekhtiev AR; Jorda R; Zhabinskii VN; Khripach VA
    Int J Mol Sci; 2022 Nov; 23(21):. PubMed ID: 36362320
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis of chiral hexacyclic steroids via [8π + 2π] cycloaddition of diazafulvenium methides.
    Lopes SM; Correia CF; Nunes SC; Pereira NA; Ferreira AR; Sousa EP; Gomes CS; Salvador JA; Pais AA; Pinho e Melo TM
    Org Biomol Chem; 2015 Sep; 13(34):9127-39. PubMed ID: 26223980
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modeling androgen receptor flexibility: a binding mode hypothesis of CYP17 inhibitors/antiandrogens for prostate cancer therapy.
    Gianti E; Zauhar RJ
    J Chem Inf Model; 2012 Oct; 52(10):2670-83. PubMed ID: 22924551
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HOXC8 inhibits androgen receptor signaling in human prostate cancer cells by inhibiting SRC-3 recruitment to direct androgen target genes.
    Axlund SD; Lambert JR; Nordeen SK
    Mol Cancer Res; 2010 Dec; 8(12):1643-55. PubMed ID: 21047772
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis of D-Ring Annulated Pyridosteroids from β-Formyl Enamides and Their Biological Evaluations.
    Nongthombam GS; Borah K; Muinao T; Silla Y; Pal M; Deka Boruah HP; Boruah RC
    ACS Comb Sci; 2019 Jan; 21(1):11-27. PubMed ID: 30576125
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis and anticancer cell potential of steroidal 16,17-seco-16,17a-dinitriles: identification of a selective inhibitor of hormone-independent breast cancer cells.
    Nikolić AR; Petri ET; Klisurić OR; Ćelić AS; Jakimov DS; Djurendić EA; Penov Gaši KM; Sakač MN
    Bioorg Med Chem; 2015 Feb; 23(4):703-11. PubMed ID: 25619894
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.